Normal Platelet Function, but Increased Platelet Activation In Vivo in Diabetic Patients

• References

• 1 Mustard JF, Packham MA. Platelets and diabetes mellitus. N Engl J Med 1984; 311: 665-667
• 2 Rao KA, Goldberg RF, Walsh PN. Platelet coagulant activities in diabetes mellitus: evidence for relationship between platelet coagulant hyperactivity and platelet volume. J Lab Clin Med 1984; 103: 82-92
• 3 Kazmier FJ, Bowie EJ W, O’Fallow WM, Zimmermann BR, Osmundson PJ, Palumbo PJ. A prospective study of peripheral occlusive arterial disease in diabetes. IV. Platelet and plasma functions. Mayo Clin Proc 1981 56. 243-253
• 4 Allessandrini P, McRae J, Feman S, FitzGerald GA. Thromboxane biosynthesis and platelet function in type I diabetes mellitus. N Engl J Med 1988; 319: 208-212
• 5 Davi G, Catalano I, Perez T, Notarbartolo A, Strano A, Ciabattoni G, Patrono C. Increased urinary excretion of 11-dehydro-thromboxane B₂ in type 2 diabetes mellitus. Thromb Haemostas 1989; 62: 244
• 6 FitzGerald GA, Smith B, Pedersen AK, Brash AR. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 1984; 310: 1065-1068
• 7 Cerletti C, Minoldo S, Bucchi F, Del Maschio A, de Gaetano G. Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors. Biochem Pharmacol 1986; 35: 1201-1203
• 8 Ciabattoni G, Maclouf J, Catella F, FitzGerald GA, Patrono C. Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. Biochim Biophys Acta 1987; 918: 293-297
• 9 Di Minno G, Silver MJ, Cerbone AM, Murphy S. Trial of repeated low-dose aspirin in diabetic angiopathy. Blood 1986; 68: 886-891